Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) (HIT)
Sponsor: Marshall University
Listed as NCT03147638, this PHASE3 trial focuses on Heparin-induced Thrombocytopenia and remains ongoing. Sponsored by Marshall University, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Sep 2018 — Sep 2020 [monthly]
Recruiting PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Marshall University
For direct contact, visit the study record on ClinicalTrials.gov .